CEMIP and pulmonary fibrosis: Recent findings have demonstrated that CEMIP exhibits pro-fibrotic functions and acts as a therapeutic target of pirfenidone for the treatment of mild-to-moderate idiopathic pulmonary fibrosis (IPF) [34].